ArmaGen Technologies Company

ArmaGen is a developer of therapies designed to address neurological complications. The company's pipeline of innovative therapies penetrate the blood-brain barrier to treat neurological complications of many diseases, including lysosomal storage disorders (LSDs), Alzheimer's and Parkinson's, enabling patients suffering from neurodegenerative disorders to get improved treatment.
Technology: NeuroTech
Industry: Biotechnology, Health Care, Medical
Headquarters: Santa Monica, California, United States
Founded Date: 2001-01-01
Employees Number: 11-50
Funding Status: M&A
Investors Number: 4
Total Funding: $35.5M
Estimated Revenue: $1M to $10M
Last Funding Type: Undisclosed

Visit Website
Register and Claim Ownership